Apyx Medical Q1 revenue $10.2M (-16% YoY); net loss $7.6M; Chairman retires

Apyx Medical Corp

2024-Q1 EPS reported -$0.22 revenue$10,244,000

Total revenue $10.2M (-16% YoY); Advanced Energy $7.5M (-23%); OEM $2.8M (+14%).
Net loss $7.6M ($0.22/share) vs $3.5M ($0.10) loss a year ago; Adjusted EBITDA loss $5.3M vs $4.0M.
Reaffirms FY2024 guidance: revenue $49.7M-$52.9M; net loss expected $24.3M-$26.5M.
Chairman Andrew Makrides retires after 42 years; Stavros Vizirgianakis elected Chairman effective May 7, 2024.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Apyx Medical Corp reported first quarter ended March 31, 2024 results: revenue $10.2 million, net income $7.6 million, EPS $0.22 per share. Guidance reaffirmed.

Period: first quarter ended March 31, 2024
Revenue: $10.2 million
Net income: $7.6 million
EPS: $0.22 per share
Guidance: reaffirmed
Result: reported results

Exact text from the filing

quarter ended March 31, 2024; and reaffirmed its financial expectations for the full year ending December 31, 2024 First Quarter 2024 Financial Summary : • Total revenue of $10.2 million, a decrease of 16% year-over-year. ◦ Advanced Energy revenue of $7.5 million, a decrease of 23% year-over-year. ◦ OEM revenue of $2.8 million, an increase of 14% year-over-year.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Apyx Medical Corp reported year ending December 31, 2024 results: revenue $49.7 million to $52.9 million. Guidance reaffirmed.

Period: year ending December 31, 2024
Revenue: $49.7 million to $52.9 million
Guidance: reaffirmed
Result: guidance update

Exact text from the filing

respectively . Full Year 2024 Financial Outlook: The Company is reaffirming its financial guidance for the year ending December 31, 2024: • Total revenue in the range of $49.7 million to $52.9 million, representing a decrease of approximately 5% to growth of approximately 1% year-over-year, compared to total revenue of $52.3 million for the year ended December

View on SEC.gov

1050 earnings releases filed in the last 30 days. Browse all earnings releases →

Apyx Medical Corp filing history →

Source: SEC EDGAR

accession 0000719135-24-000024

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.